PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 1, 2024Vaccines8 citationsOpen Access

Cost-Effectiveness Analysis of Herpes Zoster Vaccination in a Chinese Population: Recombinant Subunit Vaccine versus Live Attenuated Vaccine

View Full Paper
JWJiaqi WangPJPengfei JinHJHui Jin

Key Points

Key points are not available for this paper at this time.

Abstract

Currently, the recombinant subunit vaccine and live attenuated vaccine in the prevention of herpes zoster are approved for marketing in China. This study aims to evaluate the cost-effectiveness of the recombinant subunit vaccine and the live attenuated vaccine in the Chinese population.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wang et al. (2024) studied this question.

synapsesocial.com/papers/68e5dc4ab6db643587571acchttps://doi.org/10.3390/vaccines12080872
Ask AI
Helpful
Bookmark
Share
View Full Paper